Infinitopes
Infinitopes is an Oxford University spinout biotech company (founded 2021, based at the BioEscalator in Oxford, UK) developing off-the-shelf precision cancer vaccines aimed at preventing deaths from cancer metastases. Its proprietary Precision Immunomics platform identifies tumor-specific antigens by integrating immunopeptidomics, advanced laboratory methods, machine learning, and validated biological testing across cancer types, paired with engineered viral vectors that elicit protective CD8 T-cell responses. Surfaced in the API Evangelist network as a portfolio company of Amplify Partners (also supported by Cancer Research UK). This is a digital-biology company profile; Infinitopes publishes no public developer portal, API documentation, SDKs, or technical integration surface at this time.
Infinitopes is profiled on the APIs.io network. Tagged areas include Company, Digital Biology, Biotechnology, Cancer Vaccines, and Immunotherapy.
Infinitopes’ developer surface includes engineering blog, support, and 3 more developer resources.
Kin Score
Security Posture 1
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Resources
Access & Security 1
Authentication, authorization, and security posture
Operate 1
Status, limits, changes, and where to get help
Commercial 1
Pricing, plans, and the legal terms of use
Company 2
The organization behind the API